Harbour Investments’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2
Closed -$183 4721
2025
Q4
$183 Buy
+2
New +$191 ﹤0.01% 3686
2024
Q4
Sell
-19
Closed -$1.55K 3533
2024
Q3
$1.55K Buy
19
+8
+73% +$617 ﹤0.01% 2993
2024
Q2
$948 Sell
11
-38
-78% -$3.07K ﹤0.01% 3000
2024
Q1
$4K Buy
+49
New +$3.83K ﹤0.01% 2580
2023
Q2
Sell
-50
Closed -$2.94K 3071
2023
Q1
$2.94K Hold
50
﹤0.01% 2463
2022
Q4
$3.08K Hold
50
﹤0.01% 2394
2022
Q3
$3K Hold
50
﹤0.01% 2321
2022
Q2
$3K Buy
+50
New +$3.2K ﹤0.01% 2321
2021
Q4
$2K Sell
50
-7
-12% -$408 ﹤0.01% 2401
2021
Q3
$4K Sell
57
-113
-66% -$7.85K ﹤0.01% 3072
2021
Q2
$14K Buy
170
+2
+1% +$152 ﹤0.01% 2542
2021
Q1
$11K Buy
+168
New +$13.2K ﹤0.01% 2555

Other funds holding HQY

Harbour Investments's HQY Position: Q1 2026 in Review

Harbour Investments sold out of HealthEquity (HQY) in Q1 2026, closing a stake of 2 shares — an estimated $183 sold.

Harbour Investments first reported a position in HQY in Q1 2021 and held it in 12 quarters. The position peaked at $14K in Q2 2021. 485 funds tracked by Wall St. Rank hold HQY as of Q1 2026.

  • Harbour Investments reported no remaining HealthEquity position as of Q1 2026 after selling out during the quarter.
  • Harbour Investments sold 2 HealthEquity shares in Q1 2026, an estimated $183.
  • Harbour Investments first reported a position in HealthEquity in Q1 2021 and held it in 12 quarters.
  • Harbour Investments's HealthEquity position peaked at $14K in Q2 2021.
  • 485 funds tracked by Wall St. Rank held HealthEquity as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.